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Abstract 
 
Mutagenesis is the replacement of nucleotides at the DNA level and one of the 
novel technologies used to produce it is by site directed mutagenesis.  NALP3 is a 
gene which encodes the protein cryopyrin.  The protein is produced as an immune 
response, however if there is some mutation in the NALP3 gene the outcomes are 
different autoinflammatory diseases.  Till date more than forty different mutations 
have been identified for this gene but among them the most important and 
frequently occurring diseases are: chronic infantile neurological cutaneous and 
articular syndrome (CINCA)/NOMID neonatal onset multisystem inflammatory 
disease, Muckle-Wells Syndrome (MWS), and familial cold urticaria (FCU).  All 
of these diseases have some common inflammatory signs as urticaria, fever and 
arthralgia.  The NALP3 gene contains 3100bp nucleotide sequence, 1550 amino 
acids and is located on chromosome position 1.  In the current study we have 
created a point mutation in the NALP3 gene by replacing arginine with leucine at 
position 260. This mutation has been observed causing the above discussed 
diseases.  To get the desired mutation, site directed mutagenesis was performed by 
using mutated primers.  The mutated strand was then further sequenced and 
analyzed.  Sequencing results were very interesting and there were multiple 
mutations instead of a single point mutation.  These strange results may be due to a 
number of reasons including faulty primers, improper plasmid purification, and 
other pipetting errors.  However when the primers were aligned even though there 
were different dissimilarities between the mutant and the wild DNA, yet designed 
mutation was observed indicating the success of our project. 
 
 
 
 
 
 
 
  
Introduction 
 
Mutagenesis is the development and production of mutations by changing the 
DNA base sequence at a specific site in a genome. Mis-sense mutations 
correspond to those mutations in which the nucleotide altering the codon results in 
the production of a different amino acid (Reece, 2004) and site directed 
mutagenesis is the changing of the codon at DNA level (Glick and Pasternak, 
2003).  Different mutations in the NACHT-, Leucine rich repeat (LRR)  and PYD-
containing proteins (cryopyrin) could induce autoinflammatory syndrome-1 
(CIAS-1)/cryopyrin cause autoinflammatory diseases as Muckle Wells syndrome 
(MWS), familial cold autoinflammatory syndrome (FCAS), chronic infantile 
neurological cutaneous and articular (CINCA) syndrome also called as neonatal, 
onset multisystem inflammatory (NOMID) disease.  Currently there are more than 
forty mutations which are recognized in the CIAS-1 gene (Ivona et al., 2007).  The 
mutation R260L is a missense mutation due to which the CINCA syndrome occurs 
at exon-3 of CIAS-1 gene, which is responsible for the production of the cryopyrin 
protein (Jeanette et al., 2008). The cryopyrin associated periodic system (CAPS) is 
a complex of autosomal dominant inherited diseases and their genes are expressed 
on the leukocytes moving in the peripheral circulation (Anna and Jos, 2007).  
Different mutations occurring in the CIAS-1 gene (that encodes (NALP3)/PYPAF1 
(pyrin-containing Apaf-1–like protein) 1, 2/Cryopyrin which is the member of the 
recently discovered NALP/PYPAF, subfamily of the CATERPILLER (caspase-
recruitment domain (CARD), transcription enhancer, R (purine)-binding, pyrin, 
lots of LRR) protein family 3,4) results in different problems (Hoffman et al., 
2001; Harton et al., 2002).  The LRRs are found to be associated in recognition of 
the proteins derived from the pathogens like the heat shock proteins (hsp70) and 
thus provoke immune responses (Girardin et al., 2002).  The NLRP3 gene which 
encodes the pyrin like protein has a LRR motif, a nucleotide binding site domain 
(NBS), and a pyrin domain.  The cryopyrin protein is a part of inflammasome 
which corresponds to the apoptosis-associated-speck-like protein called 
PYCARD/ASC, which has a domain for caspase recruitment. ASC which is linked 
to cryopyrin activates the nuclear factor kB (NF-kB) (Martinon et al., 2006).   
 
Whenever there is some problem in this gene the results may be as following:  
chronic infantile neurological cutaneous and articular syndrome 
(CINCA)/NOMID, Muckle-Wells Syndrome (MWS), and familial cold urticaria 
(FCU).  As a result due to some problem in this gene (NALP3) it starts producing 
inflammasomes which then activates the caspase-1 and in turn elevates the 
secretion of Interleukin-1 β and ultimately the process of inflammation is triggered 
(Yu et al., 2006; Ebun et al., 2002).  Pyrin domain (PYD) enhances interactions 
between the proteins containing them which ultimately form a complex for 
mediating signals.  The LLRs, which is member of the CATERPILLAR family 
and subfamily NOD (nucleotide binding oligomerization domain), responds to 
intracellular stimulation and can initiate an immune response.  The three most 
important auto-inflammatory diseases caused by mutations in the CIAS-1 gene, 
FCU, MWS, and CINCA/NOMID have some same inflammatory responses as 
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fever, urticaria and arthralgia.  Those patients having CINCA syndrome have the 
most severe conditions starting from the neonatal life as polymorphonuclear 
meningitis (PMN) which results in arthropathies and neuropathies which leads to 
deafness, and visual problems.  In MWS deafness of the neurosensory organs, 
amyloidosis, and arthritis have been observed.  FCU is the mildest among all the 
diseases and it is aggravated in when the individuals are exposed to cold 
(Benedicte et al., 2004).   
 
Three mutations were found in exon-3 like R260L, R260W, and R260P. The 
codon 260 (CGA) is a hotspot of these mutations. Originally, this codon encodes 
for arginine but after mutation it encodes for leucine, tryptophan and proline, 
respectively. The substitute of arginine with these amino acids alters the structure 
and function of protein which disturbs its normal inflammatory function and cause 
disease.  The purpose of this study was to create PCR based site directed 
mutagenesis (R260L) by replacing arginine with leucine in the NALP3 gene by 
switching the nucleotide codon CGA to CTA which was further analyzed by PCR 
and sequencing. 
 
 
  
Materials and Methods 
 
 
Mutagenic primer design 
 
To design the template specific mutagenic primer, a web based primer deigning 
software; QuikChange® Primer Design Program (Stratagene, 2008) was used. The 
mutagenic oligonucleotide primer was designed according to the desired mutation 
(Appendix I). The specifications and working of the primer were as follows: 
 
The desired mutation was present in both of the mutagenic primers and it annealed 
to the opposite plasmid strand on the same sequence.  The length of the primer was 
35 nucleotide bases long, with a melting temperature (Tm) of 78.10°C.  10-15 
bases of correct nucleotide sequences were included on both sides of the desired 
mutation so that the mutation was in the middle of the primer.  The primer 
contained at least 40% GC content and terminated in one or more C or G bases.  
The forward primer used was 5'-gttctatatccactgtctagaggtgagccttgtga-3'; where as 
the reverse primer used was 5'-tcacaaggctcacctctagacagtggatatagaac-3'. 
 
 
Mutant strand synthesis  
 
Forward and reverse primers each of 35 nucleotide length were used for site 
directed mutagenesis by replacing the amino acid arginine with leucine on the 
position number 260 of the NALP3 gene by switching the nucleotide codon CGA 
to CTA. The components of the reaction mix are mixed as described in the 
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QuickChange®II Site-Directed Mutagenesis Kit (Stratagene, 2008).  The 
thermocycler was run according to the protocol by Stratagene, with 16 cycles and 
55 ºC annealing temperature. The amount of template used was 25ng and 125ng of 
both forward and reverse primers were utilized.  
 
 
Dpn I Digestion of mutant plasmids 
 
The mutant non-methylated DNA was obtained by digestion of the methylated 
wild type DNA with endonuclease Dpn-1 by using the QuickChange®II Site-
Directed Mutagenesis Kit (Stratagene, 2008). 
 
 
Transformation of XL1-Blue Supercompetent Cells 
                        
The DpnI-treated plasmid DNA was then transformed into Escherichia coli (XL1-
Blue) supercompetent cells, plated on two ampicillin containing LB agar plates at 
37οC for 16 hours. Two colonies, one from each plate, were transferred to a falcon 
tube having 5 ml LB broth containing ampicillin which was then incubated 
overnight at 37οC.  All the procedures were according to the QuickChange®II 
Site-Directed Mutagenesis Kit (Stratagene, 2008).   
 
 
Mutant plasmid DNA purification 
 
For harvesting and purification of mutant plasmid DNA from the overnight culture 
of bacteria the protocol given in the Qiagen Spin Miniprep Kit was adopted. This 
kit is based on the alkali preparation of plasmid DNA. Ten milliliter of culture was 
collected and from it plasmid was purified. Purified plasmid was stored at -20οC. 
 
 
DNA concentration of purified Mutant Plasmid DNA 
 
The DNA concentration was measured using the Nanodrop, ND-1000 (Thermo 
technologies, USA) 
 
 
Sequencing PCR  
 
After dilution of the plasmid, sequencing PCR was performed by using a left 
sequencing primer 5`-ACACACGACTGCGTCTCATC-3` which started and 
ended at 503rd nucleotide and 524th nucleotide position, respectively. As a template 
270ng of the mutated purified plasmid was used, the annealing temperature was 
50˚C, and the PCR was subjected to 40 cycles as described in BigDye terminator v 
1.1cycle sequencing kit (Applied Biosystems, 2008). 
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Purification of the Amplicon 
 
The amplicon was purified using DyeEx 2.0 Spin Kit (Qiagen, 2008) to remove 
the unincorporated dye terminator from sequencing reaction. DyeEx 2.0 Spin Kit 
contains prehydrated gel filtration  resin and can be readily used.  
 
 
Sequencing 
 
The purified mutated plasmid DNA product was then heat dried for 11-14 minutes 
at 90οC which was further resuspended in 15µl of TSR (template suppression 
reagent) according to the BigDye terminator v1.1cycle sequencing kit and then 
sequenced by using ABI 310 Genetic Analyzer (GMI, USA). 
 
 
Bioinformatics analysis 
 
The nucleotide sequence obtained from ABI 310 Genetic Analyser (GMI, USA) 
was then aligned with the wild type NALP3 gene using the software Lalign 
(Expasy, 2008). 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
Results and discussions 
 
The mutated primers replaced the nucleotide G with T on the position number 260 
in the cloned vector containing the desired gene of NALP3, as a result the amino 
acid arginine was replaced with leucine. Following successive digestion the 
mutant (non-methylated) DNA was revealed and uniform growth of the ampicillin 
resistant plasmid showed the plasmid was transformed into the E. coli competent 
cells (XL 1 blue). Excellent turbidity was observed after culturing of the two 
colonies in the LB broth which confirmed dense bacterial population.  Nanodrop 
illustrated a concentration of 365ng/µl of the plasmid and the ratio of 260/280 was 
found to be 1.83 which confirmed the purity of plasmid DNA. The sequencing 
results showed numerous unidentified nucleotides (N,s) in the mutated NALP3 
gene (Appendix II), after removing the N,s the following sequence was revealed as 
shown in Figure 1.   
 
TAAGGACACCGCACCGCAGTATAGGAGCAGGAGCTTCTGGCCTCGGCAAGACCAAGACGTGTGAGA
GCCCCGTGAGTCCCATTAAGATGGAGTTGCTGTTTGACCCCGATGATGAGCATTCTGAGCCTGTGC
ACACCGTGGTGTTCCAGGGGGCGGCAGGGATTGGGAAAACAATCCTGGCCAGGAAGATGATGTTGG
ACTGGGCGTCGGGGGACACTCTACCAAGACAGGTTTTGACTATCTGTTTCTATATTCCACTGGTCT
AAGAGGGTGAGCCCTTTGGTGACACAAGAAGGAAGCCCTGGGGGGACCCTGGATTCAATTGAAGCC
TTGCTTGGCCCCCGACCCCAAAACCCCAACCCATTCCCACAAAGATTCGTTGGAGAAAAACCCCTT
CCAAAATTCCTTCTTTCTTCATGGGACCGGGCTTTCCAATGAAGCTGTAAGGTTGCCCTTTTGACA
AGCACATTAGGGACCCGCTTTTGCACTTGACTTGGGAAAAAGGCCAAGCGGG 
Figure 1. This shows the sequence results after replacing the unidentified nucleotides 
(N,s) manually by using the web tool; Chromas lite, Softpedia, 2008 . 
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Specific base calls were made and the N,s were then substituted manually by their 
respective nucleotides from the mutant DNA by using the chromatogram.  Many 
homonucleotide runs such as repetitive sequences were observed which act as 
hotspots for mutations (Gordenin et al., 1998).  As a whole the chromatogram 
furnished a justified sequencing trace with crisp clean bands which are separated 
without any ambiguity resulting in a proper base call with little baseline noise, 
however in the first hundred nucleotides low peaks were identified, and may be 
observed as a result of the DNA polymerase slippage effect of Pfu due to 
secondary structures (Salganik et al., 1990).  An abnormal peak height of polyA 
was observed at the 2nd nucleotide which due to over condensation was not able to 
separate as a result of some interfering nucleotide, may be due to any sort of 
contamination due to improper purification of the sample.  The polyT initially is 
not being amplified and is shown at the basal line may be due to contamination.  
Many broken peaks are also observed indicating a non-specific primer which may 
be binding to more than one DNA templates.  The broken peak distortions kept on 
increasing which ultimately swamped the whole chromatogram after the 140th 
nucleotide.  Merger of many different peaks were also seen due to fact of presence 
of more than one template DNA due to contamination.  Finally the mutant DNA 
sequence was aligned against the wild type NALP3 gene by using Lalign 
(Appendix III).  The web based bioinformatics tool revealed multiple mutations 
along with a number of dissimilarities in both wild type and mutant strands, yet the 
desired mutation CGA was replaced with CTA at the nucleotide number 780 
(Appendix III).  The multiple point mutations found may be due to gene 
conversion between different homologous sequences (Igor et al., 2003).  Gel 
electrophoresis should be performed to reveal the size of the plasmid DNA, and if 
the desired plasmid DNA size is obtained only then sequencing should be 
performed, however these types of abrasions can be avoided by counter checking 
each step which might be one of our major mistakes.  The current project would be 
further utilized to check the expression and structure of proteins produced from 
this mutant NALP3 gene.  
 
 
 
Reference 
 
Anna S. and Jos W.M. (2007) Pathogenesis of familial periodic fever syndromes 
or hereditary auto inflammatory syndromes. Am J Physiol Regul Integr Comp 
Physiol, 292, (p. 86–98).  
 
Applied Biosystems. (2008) BigDye® Terminator v1.1 Cycle Sequencing Kit. 
 
Benedicte N., Isabelle C., Anne-M., Jerome F., Christine B. and Loredana L. 
(2004) Molecular basis of the spectral expression of CIAS1 mutations associated 
with phagocytic cell-mediated auto inflammatory disorders CINCA/NOMID, 
MWS and FCU.  Blood, 103, (p. 7). 
 
 5 
Ebun A., Fabio M., Philip N., Hawkins., John B., Ross., Daniel C., Swan., David 
R., Booth. and Helen J. L (2002) Association of Mutations in the 
NALP3/CIAS1/PYPAF1Gene With a Broad Phenotype Including Recurrent Fever, 
Cold Sensitivity, Sensorineural Deafness, and AA myloidosis. Arthritis & 
rheumatism, 46, (p. 2445–2452). 
 
Expasy. (2008) Available at: http://www.ch.embnet.org/ software/ LALIGN_form. 
html. [Collected 2008.10.25] 
 
Martinon F., Pétrilli V., Mayor A., Tardivel A. and Tschopp J. (2006) Gout-
associated uric acid crystals activate the NALP3 inflammasome. Nature 440, (p. 
237-241). 
 
Girardin S.E., Sansonetti P.J. and Philpott D.J. (2002) Intracellular vs extracellular 
recognition of pathogens Common concepts in mammals and flies. Trends 
Microbiol. 10, (p. 193-199). 
 
Glick B.R. and Pasternak J.J. (2003). Molecular Biotechnology 
 
Gordenin D.A. and Resnick M.A. (1998) Yeast ARMs (DNA at-risk motifs) can 
reveal sources of genome instability. Mutation Research, 400, (p. 45–58) 
 
Harton J.A., Linhoff M.W., Zhang J. and Ting J.P. (2002). Cutting edge: 
CATERPILLER: a large family of mammalian genes containing CARD, pyrin, 
nucleotidebinding, and leucine-rich repeat domains. J Immunol, 169, (p. 4088-
4093). 
 
Hoffman H.M., Mueller J.L., Broide D.H., Wanderer A.A. and  Kolodner R.D. 
(2001) Mutation of a new gene encoding a putative pyrin-like protein causes 
familial cold autoinflammatory syndrome and Muckle- Wells syndrome. Nat 
Genet, 29, (p. 301-305). 
 
Igor B.R. and Youri I. (2003) Theoretical analysis of mutation hotspots and their 
DNA sequence context specificity. Mutation Research, 544, (p. 65–85). 
 
Ivona A., Christopher D.P., Elaine F.R., James L.M., Julie Le. and Richard DK. 
(2007)   Novel CIAS1 Mutations in North American Patients and a New Cryopyrin 
Model.  Arthritis & Rheumatism, 56, (p. 1273–1285). 
 
Jeanette M.W., Tanja P.O. and Koichi S.K. (2008)   NLR proteins: integral 
members of innate immunity and mediators of inflammatory diseases.  Journal of 
Leukocyte Biology, 83, (p. 13-30.) 
 
Yu J.W., J Wu., Zhang Z., Datta P., Ibrahimi I., Taniguchi S., Sagara J., Fernandes 
A. and Alnemri E. (2005) Cryopyrin and pyrin activate caspase-1, but not NF- B, 
via ASC oligomerization. Cell Death and Differentiation, 1038, (p. 236–249).  
 
 6 
QIAGEN. (2002) DyeEx® 2.0 Spin Kit. Available at: http://www1.qiagen. 
com/literature/handbooks/literature.aspx?id=1000066. [collected  2008.10.02]  
QIAGEN. (2006) QIaprep® miniprep handbook. Available at: http:// www1. 
qiagen.com / literature/ handbooks/literature.aspx?id=1000248. [collected  
2008.10.02]  
 
Reece R.J. (2004) Analysis of Genes and Genomes. ISBN: 0-470-84379-9 New 
York, 
 
Salganik R.I., Dianov G. and Medvedev A. (1990) Cluster of point mutations 
redetermined by a quasipalindromic nucleotide sequence in plasmid pBR322 DNA. 
FEBS Lett, 261, (p.  28–30). 
 
Softpedia. (2008) Available at:http://www.softpedia.com/get/Science-CAD/ 
Chromas-Lite.shtml. [collected  2008.10.02]. 
 
Strategene. (2008) Available at:http://www.stratagene.com/tradeshows/ 
feature.aspx?fpId=118. [collected 2008.09.12]. 
 
Stratagene. (2008) QuikChange® II site-directed mutagenesis kit. Available at: 
http://www.stratagene.com/manuals/200523.pdf. [collected  2008.10.02]. 
 
 
 
Appendices 
 
 
Appendix I 
 
Wild type primer:  5'-gttctatatccactgtcgagaggtgagccttgtga-3' 
 
Mutagenic primer design 
 
 
 
 
Oligonucleotide information: 
 
Primer Name Length (nt.) Tm 
Duplex Energy at 
68°C 
Energy Cost of 
Mismatches 
g779t 35 78.10°C -41.85 kcal/mole 7.4% 
g779t_antisense 35 78.10°C -46.65 kcal/mole 6.0% 
 
Prime Primer Sequence (5' to 3') 
9t 5'-gttctatatccactgtctagaggtgagccttgtga-3' 
9t_antisense 5'-tcacaaggctcacctctagacagtggatatagaac-3' 
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Primer-template duplexes: 
 
Primer Name Primer-Template Duplex 
g779t 
5'-gttctatatccactgtctagaggtgagccttgtga-3' 
   ||||||||||||||||| ||||||||||||||||| 
agacaagatataggtgacagctctccactcggaacactgtg 
g779t_antisense 
tctgttctatatccactgtcgagaggtgagccttgtgacac 
  ||||||||||||||||| ||||||||||||||||| 
3'-caagatataggtgacagatctccactcggaacact-5' 
 
 
 
Appendix II 
 
 
DNA sequencing result 
 
 
TAAGNACACCGCACCGCAGNANAGGAGCAGGAGCTTCTGGCCTCGGCAAGACCAAGACGTGTGAGA
GCCCCGTGAGTCCCATTAAGATGGAGTTGCTGTTTGACCCCGATGATGAGCATTCTGAGCCTGTGC
ACACCGTGGTGTTCCAGGGGGCGGCAGGGATTGGGAAAACAATCCTGGCCAGGAAGATGATGTTGG
ACTGGGCGTCGGGGGACACTCTACCAAGACAGGTTTTGACTATCTGTTTCTATATTCCACTGGTCT
AAGAGGGTGAGCCCTTTGGTGACACANGAAGGANGCCNTGGGGGGACCCTGGATTCNATNGAAGCC
TTGCTTGGCCCCCGACCCCAAAACCCCANCCCNNTCCCACAAAGATTCGNTGGAGAAAAACCCCTT
CCAAAATTCCTNCTTTCTNCATGGGACCGGGCTTTCCAATGAAGCTGNNAGGNTGCCCTTTTGACN
AGCNCATTAGGGACCNGCTTTTGCACTNNACTTGGGAAAANGGCCAAGCGGG 
 
 
DNA sequencing result by removing N,s 
 
TAAGGACACCGCACCGCAGTATAGGAGCAGGAGCTTCTGGCCTCGGCAAGACCAAGACGTGTGAGA
GCCCCGTGAGTCCCATTAAGATGGAGTTGCTGTTTGACCCCGATGATGAGCATTCTGAGCCTGTGC
ACACCGTGGTGTTCCAGGGGGCGGCAGGGATTGGGAAAACAATCCTGGCCAGGAAGATGATGTTGG
ACTGGGCGTCGGGGGACACTCTACCAAGACAGGTTTTGACTATCTGTTTCTATATTCCACTGGTCT
AAGAGGGTGAGCCCTTTGGTGACACAAGAAGGAAGCCCTGGGGGGACCCTGGATTCAATTGAAGCC
TTGCTTGGCCCCCGACCCCAAAACCCCAACCCATTCCCACAAAGATTCGTTGGAGAAAAACCCCTT
CCAAAATTCCTTCTTTCTTCATGGGACCGGGCTTTCCAATGAAGCTGTAAGGTTGCCCTTTTGACA
AGCACATTAGGGACCCGCTTTTGCACTTGACTTGGGAAAAAGGCCAAGCGGG 
 
 
Appendix III 
 
Comparison of: 
(A) ./wwwtmp/.25917.1.seq Wild type 3105 bp                                  - 3105 
nt 
(B) ./wwwtmp/.25917.2.seq Mutant type 514 bp                                 - 514 
nt 
 using matrix file: DNA (5/-4), gap-open/ext: -14/-4 E(limit)   0.05 
 
  82.8% identity in 518 nt overlap (517-976:2-514); score: 1257 E(10000): 3.9e-96 
 
        520       530       540       550       560       570       
Wild   AAGGAGCACCGGAGCCAGCAGGAGAGGGAGCAGGAGCTTCTGGCCATCGGCAAGACCAAG 
       ::::: ::::: : :  :::: : ::: ::::::::::::::::: :::::::::::::: 
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Mutant AAGGA-CACCGCACC--GCAGTATAGG-AGCAGGAGCTTCTGGCC-TCGGCAAGACCAAG 
               10          20         30        40         50       
 
        580       590       600       610       620       630       
Wild   ACGTGTGAGAGCCCCGTGAGTCCCATTAAGATGGAGTTGCTGTTTGACCCCGATGATGAG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
Mutant ACGTGTGAGAGCCCCGTGAGTCCCATTAAGATGGAGTTGCTGTTTGACCCCGATGATGAG 
         60        70        80        90       100       110       
 
        640       650       660       670       680       690       
Wild   CATTCTGAGCCTGTGCACACCGTGGTGTTCCAGGGGGCGGCAGGGATTGGGAAAACAATC 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
Mutant CATTCTGAGCCTGTGCACACCGTGGTGTTCCAGGGGGCGGCAGGGATTGGGAAAACAATC 
        120       130       140       150       160       170       
 
        700       710       720       730        740       750      
Wild   CTGGCCAGGAAGATGATGTTGGACTGGGCGTCGGGG-ACACTCTACCAAGACAGGTTT-G 
       :::::::::::::::::::::::::::::::::::: ::::::::::::::::::::: : 
Mutant CTGGCCAGGAAGATGATGTTGGACTGGGCGTCGGGGGACACTCTACCAAGACAGGTTTTG 
        180       190       200       210       220       230       
 
          760        770         780         790          800       
Wild   ACTATCTGTT-CTATAT-CCACTG-TCGA-GAGG-TGAGCCTT---GTGACACAG--AGG 
       :::::::::: :::::: :::::: :: : :::: :::::: :   ::::::::   ::: 
Mutant ACTATCTGTTTCTATATTCCACTGGTCTAAGAGGGTGAGCCCTTTGGTGACACAAGAAGG 
        240       250       260       270       280       290       
 
            810         820                 830       840           
Wild   AG--CCTGGGGGA--CCTGA--TCA--TGA------GCTGCTGCCCCGACCC--AAACCC 
       :   ::::::::   ::::   :::  :::      :::    :::::::::  :::::: 
Mutant AAGCCCTGGGGGGACCCTGGATTCAATTGAAGCCTTGCTTGGCCCCCGACCCCAAAACCC 
        300       310       320       330       340       350       
 
        850         860           870          880         890      
Wild   --ACCCAT--CCACAA-GAT-CGT--GAGAAAACCC---TCCAGAATCC--TCTTCCT-C 
         ::::::  :::::: ::: :::  ::::::: ::   :::: ::: :  :::: :: : 
Mutant CAACCCATTCCCACAAAGATTCGTTGGAGAAAAACCCCTTCCAAAATTCCTTCTTTCTTC 
        360       370       380       390       400       410       
 
           900           910        920          930         940    
Wild   ATGG-AC--GGCTT--CGATGA-GCTGCAAGGT-GCC--TTTGACGAGCACATA--GGAC 
       :::: ::  :::::  : :::: :::: ::::: :::  :::::: :::::::   :::: 
Mutant ATGGGACCGGGCTTTCCAATGAAGCTGTAAGGTTGCCCTTTTGACAAGCACATTAGGGAC 
        420       430       440       450       460       470       
 
             950          960       970       
Wild   C-GCTCT-GCACT-GACT--GGCAGAAGGCCGAGCGGG 
       : ::: : ::::: ::::  :: : :::::: :::::: 
Mutant CCGCTTTTGCACTTGACTTGGGAAAAAGGCCAAGCGGG 
        480       490       500       510     
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